Detail Information of Exogenous Modulation

General Information of Drug Transporter (DT)
DT ID DTD0028 Transporter Info
Gene Name SLC47A2
Transporter Name Multidrug and toxin extrusion protein 2
Gene ID
146802
UniProt ID
Q86VL8
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Approved Drug

  Quinine

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Quinine inhibits the transportation of 1-methyl-4-phenylpyridinium by SLC47A2 (IC50 = 6.4 microM) [1]

Affected Drug/Substrate

 1-methyl-4-phenylpyridinium Modulation Type Inhibition

Cell System

 Chinese hamster ovary (CHO) cells-MATE2

  DT Modulation 2

 Quinine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 23.1 microM) [2]

Affected Drug/Substrate

 Tetraethylammonium Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  Cimetidine

            2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cimetidine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 7.3 microM) [2]

Affected Drug/Substrate

 Tetraethylammonium Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  DT Modulation 2

 Cimetidine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 2.1 microM) [3]

Affected Drug/Substrate

 Tetraethylammonium Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  Amantadine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Amantadine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 1167 microM) [2]

Affected Drug/Substrate

 Tetraethylammonium Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  Cetirizine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cetirizine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 817.6 microM) [2]

Affected Drug/Substrate

 Tetraethylammonium Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  Chlorpheniramine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Chlorpheniramine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 191.2 microM) [2]

Affected Drug/Substrate

 Tetraethylammonium Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  Desipramine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Desipramine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 283 microM) [2]

Affected Drug/Substrate

 Tetraethylammonium Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  Diltiazem

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Diltiazem inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 117 microM) [2]

Affected Drug/Substrate

 Tetraethylammonium Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  Diphenhydramine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Diphenhydramine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 266.5 microM) [2]

Affected Drug/Substrate

 Tetraethylammonium Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  Disopyramide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Disopyramide inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 291.6 microM) [2]

Affected Drug/Substrate

 Tetraethylammonium Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  Famotidine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Famotidine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 9.7 microM) [2]

Affected Drug/Substrate

 Tetraethylammonium Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  Imipramine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Imipramine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 182.9 microM) [2]

Affected Drug/Substrate

 Tetraethylammonium Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  Metformin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Metformin inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 6515.7 microM) [2]

Affected Drug/Substrate

 Tetraethylammonium Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  Pramipexole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Pramipexole inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 24.1 microM) [2]

Affected Drug/Substrate

 Tetraethylammonium Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  Procainamide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Procainamide inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 178.1 microM) [2]

Affected Drug/Substrate

 Tetraethylammonium Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  Ranitidine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ranitidine inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 25 microM) [2]

Affected Drug/Substrate

 Tetraethylammonium Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  Verapamil

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Verapamil inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 32.1 microM) [2]

Affected Drug/Substrate

 Tetraethylammonium Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  Carvedilol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Carvedilol inhibits the activity of SLC47A2 (IC50 = 202 microM) [6]

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  Cobicistat

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cobicistat inhibits the activity of SLC47A2 (IC50 = 3.2 microM) [7]

  Ritonavir

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ritonavir inhibits the activity of SLC47A2 (IC50 = 90 microM) [7]

  Cyclosporine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cyclosporine inhibits the expression of SLC47A2 [9]

  Estradiol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Estradiol increases the expression of SLC47A2 [10]

  Acetaminophen

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Acetaminophen inhibits the expression of SLC47A2 [11]

  Pyrimethamine

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Pyrimethamine inhibits the activity of SLC47A2 [12]

  Cannabidiol

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cannabidiol inhibits the expression of SLC47A2 [13]

  Titanium dioxide

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Titanium dioxide inhibits the expression of SLC47A2 [14]

  Plazomicin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Plazomicin inhibits the activity of SLC47A2 [15]

  Itraconazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Itraconazole inhibits the activity of SLC47A2 [16]

  Ketoconazole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Ketoconazole inhibits the activity of SLC47A2 [16]

Drug in Phase 4 Trial

  Talipexole

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Talipexole inhibits the transportation of Tetraethylammonium by SLC47A2 (Ki = 119.5 microM) [2]

Affected Drug/Substrate

 Tetraethylammonium Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

Drug in Phase 2 Trial

  Genistein

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Genistein increases the expression of SLC47A2 [10]

Discontinued Drug

  DX-619

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 DX-619 inhibits the transportation of Creatinine by SLC47A2 (Ki = 0.1 microM) [4]

Affected Drug/Substrate

 Creatinine Modulation Type Inhibition

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

Investigative Drug

  Tetraethylammonium

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tetraethylammonium modulates the activity of SLC47A2 [20]

Natural Product

  Cigarette smoke condensate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Cigarette smoke condensate inhibits the activity of SLC47A2 (IC50 = 61.4 microM) [5]

Cell System

 Human embryonic kidney 293 cells (HEK293)-MATE2

  Green tea

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Green tea inhibits the transportation of Metformin by SLC47A2 [8]

Affected Drug/Substrate

 Metformin Modulation Type Inhibition

Cell System

 Human enterocyte-like 2 cell (Caco-2)-MATE2

  Tobacco Smoke Pollution

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Tobacco Smoke Pollution inhibits the activity of SLC47A2 [5]

Environmental toxicant

  Polychlorinated dibenzodioxin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Polychlorinated dibenzodioxin increases the expression of SLC47A2 [9]

Carcinogen

  Benzo(a)pyrene

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Benzo(a)pyrene increases the expression of SLC47A2 [9]

Pesticide/Insecticide

  Clothianidin

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Clothianidin inhibits the activity of SLC47A2 [19]

Health and Environmental Toxicant

  Lead

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Lead affects the expression of SLC47A2 [17]

  Diethylhexyl Phthalate

            1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation 1

 Diethylhexyl Phthalate inhibits the expression of SLC47A2 [18]
References
1 Molecular determinants of ligand selectivity for the human multidrug and toxin extruder proteins MATE1 and MATE2-K. J Pharmacol Exp Ther. 2012 Jun;341(3):743-55.
2 Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells. J Pharmacol Exp Ther. 2009 Apr;329(1):185-91.
3 Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney. J Pharmacol Exp Ther. 2012 Feb;340(2):393-403.
4 Prediction of fluoroquinolone-induced elevation in serum creatinine levels: a case of drug-endogenous substance interaction involving the inhibition of renal secretion. Clin Pharmacol Ther. 2011 Jan;89(1):81-8.
5 Inhibition of organic anion transporter (OAT) activity by cigarette smoke condensate. Toxicol In Vitro. 2017 Oct;44:27-35.
6 Selective Inhibition on Organic Cation Transporters by Carvedilol Protects Mice from Cisplatin-Induced Nephrotoxicity. Pharm Res. 2018 Sep 6;35(11):204.
7 No Inhibition of MATE1/2K-Mediated Renal Creatinine Secretion Predicted With Ritonavir or Cobicistat. J Pharm Sci. 2019 Apr 26. pii: S0022-3549(19)30289-8.
8 Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein. PLoS One. 2015 Oct 1;10(10):e0139370.
9 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
10 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
11 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
12 Interactions between Oroxylin A with the solute carrier transporters and ATP-binding cassette transporters: Drug transporters profile for this flavonoid. Chem Biol Interact. 2020 Jun 1;324:109097.
13 Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Sci Rep. 2020 Nov 26;10(1):20622.
14 Genome-wide DNA methylome and transcriptome changes induced by inorganic nanoparticles in human kidney cells after chronic exposure. Cell Biol Toxicol. 2022 Jan 1.
15 No Effect of Plazomicin on the Pharmacokinetics of Metformin in Healthy Subjects. Clin Pharmacol Drug Dev. 2019 Jan 3.
16 Evaluation of Ketoconazole and Its Alternative Clinical CYP3A4/5 Inhibitors as Inhibitors of Drug Transporters: The In Vitro Effects of Ketoconazole, Ritonavir, Clarithromycin, and Itraconazole on 13 Clinically-Relevant Drug Transporters. Drug Metab Dispos. 2016 Mar;44(3):453-9.
17 RNA-Seq of Human Neural Progenitor Cells Exposed to Lead (Pb) Reveals Transcriptome Dynamics, Splicing Alterations and Disease Risk Associations. Toxicol Sci. 2017 Sep 1;159(1):251-265.
18 Di-(2-ethylhexyl)-phthalate induces apoptosis via the PPAR Gamma/PTEN/AKT pathway in differentiated human embryonic stem cells. Food Chem Toxicol. 2019 Sep;131:110552.
19 Neonicotinoid pesticides poorly interact with human drug transporters. J Biochem Mol Toxicol. 2019 Oct;33(10):e22379.
20 Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. Biochem Pharmacol. 2007 Jul 15;74(2):359-71.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.